November Research Group
November Research Group provides pharmacovigilance software that speeds adverse event processing. Genpact acquired NRG to power its Pharmacovigilance AI (PVAI) product, expanding automation capabilities. The core technology combines optical character recognition, robotic process automation, natural language processing, and machine learning to extract and code AE data from unstructured sources. As a B2B SaaS for life sciences, it targets pharma and biotech customers and integrates with PV workflows. The platform scales with more AE data, delivering real-time predictive insights and a more efficient PV operating model.
November Research Group
November Research Group provides pharmacovigilance software that speeds adverse event processing. Genpact acquired NRG to power its Pharmacovigilance AI (PVAI) product, expanding automation capabilities. The core technology combines optical character recognition, robotic process automation, natural language processing, and machine learning to extract and code AE data from unstructured sources. As a B2B SaaS for life sciences, it targets pharma and biotech customers and integrates with PV workflows. The platform scales with more AE data, delivering real-time predictive insights and a more efficient PV operating model.